Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$11,734,429
+$1,026,002 QoQ
Shares Held
46,204
+5.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#1,015
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. JNJ ranks #1 (30.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
46,204 | $11,734,429 | |
| 2 | LLY |
ELI LILLY & Co
|
4,626 | $5,548,563 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,944 | $3,976,304 | |
| 4 | NVS |
Novartis AG
|
22,990 | $3,602,992 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
26,787 | $3,384,269 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,197 | $2,143,291 | |
| 7 | ABBV |
AbbVie Inc.
|
7,045 | $1,772,803 | |
| 8 | BIIB |
Biogen Inc.
|
7,285 | $1,573,997 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,734,429 | 46,204 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $10,708,427 | 43,808 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $8,181,975 | 39,536 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $6,761,525 | 36,466 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,928,937 | 32,268 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,495,937 | 33,140 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,282,440 | 22,697 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,989,268 | 24,616 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,233,909 | 15,284 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,422,996 | 15,317 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,975,864 | 12,606 | Shares | Sole | 2024-04-16 | |
| 2023-09-30 | $2,470,973 | 15,865 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,191,815 | 13,242 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $2,022,285 | 13,047 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $3,209,730 | 18,170 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,634,253 | 10,004 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,149,291 | 12,108 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,892,816 | 10,680 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $852,955 | 4,986 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,011,313 | 6,262 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $854,671 | 5,188 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $746,806 | 4,544 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $665,087 | 4,226 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $626,189 | 4,206 | Shares | Sole | 2020-11-20 | |
| 2020-06-30 | $355,793 | 2,530 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $507,341 | 3,869 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||